Triple negative breast cancer (TNBC), defined as estrogen receptor (ER)-, progesterone receptor (PgR)-, and human epidermal growth factor receptor 2 (HER2)-negative breast cancer (BC) has poor prognosis compared to other BC subtypes (1). This evidence concerns the gene PGR and breast cancer.